Neubeck Lis, Redfern Julie, Fernandez Ritin, Briffa Tom, Bauman Adrian, Freedman Saul Ben
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia.
Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):281-9. doi: 10.1097/HJR.0b013e32832a4e7a.
Coronary heart disease (CHD) is a leading cause of death globally. Despite proven health benefits and international recommendations, attendance at cardiac rehabilitation programs is poor. Telehealth (phone, Internet, and videoconference communication between patient and health-care provider) has emerged as an innovative way of delivering health interventions. This review aimed to determine telehealth effectiveness in CHD management. Study design includes systematic review with meta-analysis. Randomized controlled trials evaluating telehealth interventions in patients with CHD were identified by searching multiple electronic databases, reference lists, relevant conference lists, gray literature, and key-word searching of the Internet. Studies were selected if they evaluated a telephone, videoconference, or web-based intervention, provided objective measurements of mortality, changes in multiple risk factor levels or quality of life. In total, 11 trials were identified (3145 patients). Telehealth interventions were associated with nonsignificant lower all-cause mortality than controls [relative risk=0.70, 95% confidence interval (CI)=0.45-1.1; P=0.12]. These interventions showed a significantly lower weighted mean difference (WMD) at medium long-term follow-up than controls for total cholesterol (WMD=0.37 mmol/l, 95% CI=0.19-0.56, P<0.001), systolic blood pressure (WMD=4.69 mmHg, 95% CI=2.91-6.47, P<0.001), and fewer smokers (relative risk = 0.84, 95% CI=0.65-0.98, P = 0.04). Significant favorable changes at follow-up were also found in high-density lipoprotien and low-density lipoprotein. In conclusion, telehealth interventions provide effective risk factor reduction and secondary prevention. Provision of telehealth models could help increase uptake of a formal secondary prevention by those who do not access cardiac rehabilitation and narrow the current evidence-practice gap.
冠心病(CHD)是全球主要的死亡原因之一。尽管心脏康复计划已被证明对健康有益且有国际推荐,但参与该计划的情况却很不理想。远程医疗(患者与医疗服务提供者之间通过电话、互联网和视频会议进行沟通)已成为提供健康干预措施的一种创新方式。本综述旨在确定远程医疗在冠心病管理中的有效性。研究设计包括系统评价和荟萃分析。通过检索多个电子数据库、参考文献列表、相关会议列表、灰色文献以及在互联网上进行关键词搜索,确定了评估冠心病患者远程医疗干预措施的随机对照试验。如果研究评估了电话、视频会议或基于网络的干预措施,并提供了死亡率、多种危险因素水平变化或生活质量的客观测量数据,则将其纳入研究。总共确定了11项试验(3145名患者)。与对照组相比,远程医疗干预措施与全因死亡率的降低无显著差异[相对风险=0.70,95%置信区间(CI)=0.45 - 1.1;P = 0.12]。在中长期随访中,这些干预措施显示,与对照组相比,总胆固醇的加权平均差(WMD)显著降低(WMD = 0.37 mmol/L,95% CI = 0.19 - 0.56,P < 0.001),收缩压(WMD = 4.69 mmHg,95% CI = 2.91 - 6.47,P < 0.001),吸烟者也更少(相对风险 = 0.84,95% CI = 0.65 - 0.98,P = 0.04)。在高密度脂蛋白和低密度脂蛋白方面,随访时也发现了显著的有利变化。总之,远程医疗干预措施可有效降低危险因素并进行二级预防。提供远程医疗模式有助于增加那些未参与心脏康复的人群对正式二级预防的接受度,并缩小当前证据与实践之间的差距。